Successful treatment of pyoderma gangrenosum associated with IgA gammopathy with the IL-1 receptor antagonist anakinra

被引:3
|
作者
Rousset, P. [1 ]
Dugourd, P. M. [1 ]
Lanteri, A. [2 ]
Montaudie, H. [1 ,3 ]
Passeron, T. [1 ,3 ]
机构
[1] Univ Cote Azur, CHU Nice, Dermatol Dept, Nice, France
[2] Ctr Hosp Antibes Juan Les Pins, Dept Internal Med, Antibes, France
[3] Univ Cote Azur, Ctr Mediterraneen Med Mol, INSERM U1065, Nice, France
关键词
ACNE; ARTHRITIS;
D O I
10.1111/jdv.17204
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E447 / E450
页数:4
相关论文
共 50 条
  • [1] Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients
    Beynon, Celia
    Chin, Mei Fong
    Hunasehally, Prasad
    Bhagwandas, Krishnan
    Bevan, Martin
    Taylor, Marisa
    Lawson, Thomas
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (03) : 181 - 183
  • [2] Successful treatment of pyoderma gangrenosum with the interleukin-1 receptor antagonist anakinra: a case series of three patients
    Chin, M. F.
    Beynon, C. R.
    Lawson, T.
    Hunasehally, P.
    Bhagwandas, K.
    Bevan, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 : 67 - 68
  • [3] Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra
    Botsios, C.
    Sfriso, P.
    Punzi, L.
    Todesco, S.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2007, 36 (03) : 236 - 237
  • [4] TREATMENT OF SYSTEMIC JUVENILE XANTHOGRANULOMA WITH IL-1 RECEPTOR ANTAGONIST ANAKINRA
    Akshintala, Srivandana
    Rossi, Christopher
    Ladisch, Stephan
    Greenberg, Jay
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E70 - E70
  • [5] Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra
    Brenner, M.
    Ruzicka, T.
    Plewig, G.
    Thomas, P.
    Herzer, P.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) : 1199 - 1201
  • [6] Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum
    Shareef, M. S.
    Munro, L. R.
    Owen, R. G.
    Highet, A. S.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2012, 37 (02) : 146 - 148
  • [7] Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
    MS Camacho Lovillo
    E Iglesias
    O Neth
    V Santa-María
    JL Gavilán
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [8] Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG
    Treudler, Regina
    Kauer, Friederike
    Simon, Jan Christoph
    [J]. ACTA DERMATO-VENEREOLOGICA, 2007, 87 (03) : 280 - 281
  • [9] Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra)
    Vounotrypidis, P
    Sakellariou, GT
    Zisopoulos, D
    Berberidis, C
    [J]. RHEUMATOLOGY, 2006, 45 (04) : 491 - 492
  • [10] AN IL-1 RECEPTOR ANTAGONIST (ANAKINRA) AS A THERAPEUTIC OPTION FOR TREATMENT-RESISTANT SEIZURES (TRS)
    Rahimian, V.
    Jyonouchi, H.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A89 - A89